Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition

Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is increasing at a near epidemic rate. We investigated whether the mammalian (or mechanistic) target of rapamycin (mTOR) inhibitor, rapamycin, can be used as a concurrent agent to standard-of-care cisplatin/ra...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Coppock, Joseph D, Wieking, Bryant G, Molinolo, Alfredo A, Gutkind, J Silvio, Miskimins, W Keith, Lee, John H
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press Inc. 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3664994/
https://ncbi.nlm.nih.gov/pubmed/23730210
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky